|
Title
|
Published
|
Price
|
|
Regenerative Medicines: Bone and Joint Applications
By: BCC Research
REPORT HIGHLIGHTS
Overall sales in the regenerative medicine productsmarket were worth $1.1 billion in 2007, and remained flat into 2009. By 2014, sales are projected to increase to nearly $1.8 billion, for a
|
more...
Search inside this report
|
10/1/2009
|
$4,850.00
|
|
Stem Cell Markets
By: Trimark Publications
A stem cell is an extraordinary type of cell that has the ability to self-renew for long periods of time and to differentiate into specialized cells under appropriate physiological or experimental conditions. Traditionally, stem cells
|
more...
|
6/1/2009
|
$3,400.00
|
|
Stem Cell Research and Tissue Engineering: A Boon for Dental Tissue Regeneration
By: GlobalData
Stem Cell Research and Tissue Engineering: A Boon for Dental Tissue Regeneration Summary GlobalData viewpoints are an essential source of high quality information on all key events in the medical equipment industry. GlobalData viewpoints are typically our
|
more...
|
5/11/2009
|
$500.00
|
|
Growth Factors (Blood And Tissue)
By: Global Industry Analysts
This report analyzes the worldwide markets for Growth Factors (Blood And Tissue) in Millions of US$. The major product segments analyzed are Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins), and Tissue Growth
|
more...
|
10/1/2008
|
$3,950.00
|
|
Advances in Replacement Organs and Tissue Engineering (Technical Insights)
By: Frost & Sullivan
Shortage of Replacement Organs Opens up Opportunities for Tissue Engineering Technology
Over the last decade, tissue engineering has stepped out of the realm of science fiction, into research labs and hospitals all over the
|
more...
|
9/30/2008
|
$6,500.00
|
|
Stem Cells in Regenerative Medicine 2008
By: Select Biosciences Limited
This is the latest and most up-to-date Worldwide Stem Cells Market Report from Select Biosciences. This report focuses on the worldwide Regenerative Medicine/Cellular Therapy Marketplace which is a major segment of the overall stem cells
|
more...
|
9/1/2008
|
$4,860.00
|
|
Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
By: Kalorama Information
With their ability to differentiate and become an ongoing source of cells that make up critical tissues and organs, stem cells have potential for new regenerative therapies and as new research tools for drug developers
|
more...
Buy by the section | Search inside this report
|
3/1/2008
|
$3,995.00
|
|
Tissue Engineering and Cell Transplantation: Technologies, Opportunities, and Evolving Markets in the U.S.
By: Medtech Insight
Due to the large number of potential patients targeted by tissue engineering and organ regeneration products, and the major healthcare costs associated with existing treatments for these patients, the potential dollar volume for tissue engineering
|
more...
Search inside this report
|
7/1/2007
|
$4,750.00
|
|
Stem Cell - Analysis and Market Forecasts, 2006-2016
By: RRY Publications
Sales of stem cell products in the United States reached $16.4 million in 2006 and are expected to surpass $35 million in 2007, according to author Robin R. Young, a medical industry analyst who has
|
more...
|
3/1/2007
|
$2,995.00
|
|
Tissue Engineering & Stem Cell Technology Report 2007
By: Visiongain
The market potential of this technology is so huge that revenues may be in excess of $10 billion by 2013. This is a market that you should be part of - NOW!! With a
|
more...
|
2/28/2007
|
$2,210.00
|
|
Hitting the Bull's-Eye with Your Eyes Closed: The Stem Cell Magic Bullet
By: IDC
This Health Industry Insights Perspective describes analyst perspectives on emerging efforts to develop stem cells as therapeutic solutions. Despite only nascent understanding of stem cells and how they work, research is advancing in several
|
more...
Search inside this report
|
12/22/2006
|
$500.00
|
|
New Options for Treating Neurological Disease: Stem Cell Therapy
By: Decision Resources
Stem cell therapy development is challenged by controversy, intellectual property issues, and a
high failure rate. Despite these challenges, stem cell therapy presents some of the most promising
options for hard-to-treat and highly degenerative neurological
|
more...
|
12/6/2006
|
$1,112.50
|
|
European Markets for Advanced Wound Management
By: Frost & Sullivan
Research Overview
This Frost & Sullivan research service titled European Markets for Advanced Wound Management provides an analysis of wound dressings and therapies that fall into the category of advanced wound management products. This
|
more...
|
10/9/2006
|
$6,500.00
|
|
Impact of Nano Materials in Drug Delivery & Human Tissue Engineering
By: Drug and Market Development Publishing
D&MD’s new market analysis report - Impact of Nano Materials in Drug Delivery & Human Tissue Engineering - provides a market driven top down approach that identifies existing products using nano based knowledge to strengthen
|
more...
Search inside this report
|
10/1/2006
|
$4,950.00
|
|
Commercial Insight: Transplantation
By: Datamonitor
Introduction
In 2005, over 50.000 solid organ transplants were conducted in the seven major markets. In order to prevent the patient's immune system from rejecting the transplanted organ, immunosuppression therapy is required for the lifetime
|
more...
Search inside this report
|
6/30/2006
|
$15,200.00
|
|
Opportunities in Stem Cell Research and Commercialization: Technology Advances, Regulatory Impact and Key Players
By: Business Insights
Stem cell transplants are routinely used to treat patients with cancers and other disorders of the blood and the immune system and may hold the key to repairing or replacing tissue cells damaged in many
|
more...
|
3/6/2006
|
$2,875.00
|
|
Current Clinical Applications and Trials of Stem Cell - Based Therapies
By: Frost & Sullivan
Ethical Concerns Posing Challenges to the Development of Stem Cell Research Despite their potential to address several unmet medical conditions such as neurodegenerative diseases and cancer, ethical social as well as legal issues are
|
more...
|
1/10/2006
|
$6,500.00
|
|
The Market for Organ and Tissue Transplantation and Alternatives
By: BCC Research
Organ failure and tissue loss account for half the medical spending in the U.S. In theory, transplantation is the last therapeutic option available to people in the final stage of an organ or tissue failure.
|
more...
Search inside this report
|
10/1/2005
|
$4,543.00
|
|
Synthetic Blood Substitutes and Blood Products: A Market Briefing
By: Kalorama Information
In addition to being one of the most important tissues in the body, blood has emerged as a key vector in the transmission of the world's deadliest infectious diseases. With the rising demand for transfusions
|
more...
Search inside this report
|
6/1/2005
|
$995.00
|
|
Tissue Engineering: Technology, Trends, and Market Opportunities
By: Drug and Market Development Publishing
This Report provides an up-to-date, comprehensive analysis of the tissue engineering industry. The Report presents an analysis of core tissue engineering technology (cells, materials, and manufacturing) and evaluates both the technical and market challenges and
|
more...
Search inside this report
|
9/1/2004
|
$4,950.00
|
|
Strategic Analysis of the European Bone Graft Substitutes Market
By: Frost & Sullivan
Clinically Effective Procedures Replace Conventional Methods of Bone Replacement
Bone graft substitutes are quickly replacing autograft bones as the accepted standard for the treatment of musculoskeletal defects. The procedure significantly reduces the time
|
more...
|
7/30/2004
|
$4,995.00
|
|
Stem Cells--Emerging Markets and Growth Opportunities (Technical Insights)
By: Frost & Sullivan
Regenerative therapies such as stem cell manipulation are developing treatment procedures for damaged tissues and organ failures. The unique ability of stem cells to divide indefinitely and differentiate into specific cell types allows them to
|
more...
|
5/6/2004
|
$4,550.00
|
|
Tissue Engineering-Technology Developments Spur Healthcare Markets
By: Frost & Sullivan
Tissue Engineering and Regenerative Medicine Radically Modify Healthcare Standards
Radical advancements in technologies such as stem cell manipulation and three-dimensional organ printing are enabling the production of living tissues and regenerative therapies. Stem
|
more...
|
12/26/2003
|
$4,550.00
|
|
Opportunities in Stem Cell Technology
By: Kalorama Information
In the nascent, but rapidly growing field of stem cell therapies, products are a long way from being commercialized. However, the market potential for stem cell therapies products is very large. This report aims to
|
more...
Buy by the section | Search inside this report
|
2/1/2002
|
$2,625.00
|
|
U.S. Tissue Engineering Markets
By: Frost & Sullivan
Less Invasive Treatments Spurs Tissue Engineering Markets
Approximately eight million surgical procedures are performed annually in the U.S. to treat tissue damage resulting from accidents, birth defects, hereditary
disorders, and other diseases. Because traditional tissue
|
more...
|
9/1/2001
|
$3,450.00
|
|
Title
|
Published
|
Price
|
(0 items)
